Gastrointestinal Cancer News

Jeffrey M. Farma, MD, FACS, has been appointed chair of surgery at Fox Chase Cancer Center.

The FDA granted accelerated approval to repotrectinib for the treatment of adults and children 12 years and older with solid tumors that have a neurotrophic tyrosine receptor kinase gene fusion.

Only a small percentage of men recommended to undergo genetic testing due to personal or family history of cancer actually received it, according to findings published in Journal of the National Comprehensive Cancer Network.

CHICAGO — An algorithm-based default referrals system led to a fourfold increase in specialty palliative care use when implemented in a large community oncology network, results of a randomized study presented at ASCO Annual Meeting showed.

CHICAGO — A phase 2 study evaluating dostarlimab in adults with mismatch repair-deficient locally advanced rectal cancer has maintained a 100% clinical complete response rate at a median follow-up of almost 18 months.

CHICAGO — Healio once again welcomed the excitement of the Disruptive Innovator Awards, working with new partners and celebrating nine distinct areas of progress in oncology and hematology.

CHICAGO — More individuals with advanced cancers in the U.S. live within 30 miles of a clinical trial site than a decade ago, but those in rural areas, those with pancreatic disease and American Indians/Alaskan Natives still have access issues.

CHICAGO — Glucagon-like peptide-1 receptor agonists lowered the risk for obesity-related cancers compared with bariatric surgery among individuals with a BMI of at least 35, according to data presented at ASCO Annual Meeting.

CHICAGO — The microbiome profile of early-onset pancreatic adenocarcinoma is distinct from that of average-onset disease, according to findings presented at ASCO Annual Meeting.

Satish Gopal, MD, MPH, feels honored to receive this year’s ASCO Humanitarian Award.